Although, mixed results have been reported in human LF patients treated using CP (~3–4 mL/kg), and it has been proposed that matching of CP geographically, likewise the titers of nullifying antibodies per curative dosage, might be important elements in efficacious passive therapy [17,113,114,115]. Here, CP is linked to Lassa fever.